Cadrenal Therapeutics Ownership | Who Owns Cadrenal Therapeutics?
Cadrenal Therapeutics Ownership Summary
Cadrenal Therapeutics is owned by 3.78% institutional investors, 16.99% insiders, and 79.23% retail investors. Geode capital management is the largest institutional shareholder, holding 0.90% of CVKD shares.
CVKD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cadrenal Therapeutics | 3.78% | 16.99% | 79.23% |
| Sector | Healthcare Stocks | 35.38% | 11.35% | 53.27% |
| Industry | Biotech Stocks | 33.91% | 11.39% | 54.70% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Geode capital management | 21.63K | 0.90% | $110.72K |
| Vanguard fiduciary trust | 8.31K | 0.35% | $42.55K |
| Jpmorgan chase | 7.50K | 0.31% | $31.88K |
| Blackrock funding, inc. /de | 5.50K | 0.23% | $28.14K |
| Tower research capital llc (trc) | 393.00 | 0.02% | $2.01K |
| Advisor group | 300.00 | 0.01% | $1.54K |
| Destiny wealth partners | 200.00 | 0.01% | $1.02K |
| Rockefeller capital management | 150.00 | 0.01% | $768.00 |
| Morgan stanley | 100.00 | 0.00% | $512.00 |
| Wells fargo & company/mn | 99.00 | 0.00% | $507.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Destiny wealth partners | 200.00 | 0.00% | $1.02K |
| Tower research capital llc (trc) | 393.00 | 0.00% | $2.01K |
| Drw securities | - | - | - |
| Ifp advisors | 30.00 | - | $154.00 |
| Advisor group | 300.00 | - | $1.54K |
| Harbour investments | - | - | - |
| Archer investment | 35.00 | - | $179.00 |
| Jpmorgan chase | 7.50K | - | $31.88K |
| Lpl financial | - | - | - |
| Ubs group | 3.00 | - | $15.00 |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard fiduciary trust | 8.31K | - | 8.31K |
| Geode capital management | 21.63K | - | 7.10K |
| Blackrock funding, inc. /de | 5.50K | - | 1.97K |
| Destiny wealth partners | 200.00 | 0.00% | 200.00 |
| Citigroup | 1.00 | - | 1.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Drw securities | - | - | -25.15K |
| Lpl financial | - | - | -13.00K |
| Ubs group | 3.00 | - | -1.04K |
| Morgan stanley | 100.00 | - | -980.00 |
| Advisor group | 300.00 | - | -200.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 8.31K | - | 8.31K | $42.55K |
| Destiny wealth partners | 200.00 | 0.00% | 200.00 | $1.02K |
| Citigroup | 1.00 | - | 1.00 | $5.00 |
Sold Out
| Holder | Change |
|---|---|
| Harbour investments | -100.00 |
| Clearstead advisors | -150.00 |
| Lpl financial | -13.00K |
| Drw securities | -25.15K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 17 | -5.56% | 90,938 | -25.15% | 3 | 10.17% | 7 | - | 5 | 150.00% |
| Dec 31, 2025 | 18 | 5.88% | 121,486 | 6.39% | 6 | 19.52% | 7 | -12.50% | 2 | -33.33% |
| Sep 30, 2025 | 17 | 21.43% | 114,193 | 67.08% | 5 | 46.02% | 8 | 14.29% | 3 | - |
| Jun 30, 2025 | 14 | 7.69% | 68,347 | -1.38% | 3 | 24.67% | 7 | -36.36% | 3 | 200.00% |
| Mar 31, 2025 | 13 | 44.44% | 69,304 | 366.85% | 3 | 396.62% | 11 | 22.22% | 1 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 29, 2025 | Szot Matthew K | Chief Financial Officer | Sell | $69.23K |
| Oct 24, 2025 | Szot Matthew K | Chief Financial Officer | Sell | $25.18K |
| Oct 27, 2025 | Szot Matthew K | Chief Financial Officer | Sell | $25.18K |
| Oct 27, 2025 | Pham Quang X | CEO and Chairman | Sell | $18.40K |
| Oct 24, 2025 | Pham Quang X | CEO and Chairman | Sell | $15.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 13 |
| 2025 Q3 | - | 10 |
| 2025 Q1 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
CVKD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools